LEXINGTON, Mass. -- (BUSINESS WIRE) -- T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced that John McDonough, CEO of T2 Bio, will present at Oppenheimer’s 24th Annual Healthcare Conference, December 11, 2013, at 10:40am ET. Mr. McDonough will discuss how T2MR® assists in the management of sepsis, including the Company’s flagship diagnostic test, T2Candida®, which is currently in a pivotal clinical trial with results expected in 2014. T2Candida detects species-specific Candida directly from a non-blood culture, whole blood specimen in approximately three hours with a limit of detection as low as 1 CFU/mL. Additionally, Mr. McDonough will discuss applications of the Company’s T2MR technology in next-generation hemostasis measurements with T2HemoStat™.
T2Candida utilizes the Company’s industry-leading diagnostic platform, T2MR, which can detect any molecular, hemostasis or immunodiagnostic target directly from unpurified clinical samples with unparalleled speed and sensitivity. T2MR has the potential to deliver therapeutically actionable results up to 25-times faster than current methods, which could significantly impact patients’ lives and healthcare costs.
About T2 Biosystems
T2 Biosystems is developing a new class of clinical diagnostics powered by T2MR®, the world’s first direct detection technology that delivers superior sensitivity at unmatched speed to guide more effective clinical decision-making. T2 Bio’s pipeline of molecular diagnostic and hemostasis products is focused on conditions where rapid and accurate results will have the greatest impact on patients’ lives and healthcare costs. The Company’s lead products, T2Candida® and T2Bacteria™, identify life-threatening pathogens associated with sepsis directly from whole blood up to 25-times faster than blood culture. www.t2biosystems.com.
T2Candida is currently intended for investigational use only. The performance characteristics of this product have not been established.
T2Bacteria and T2Hemostat are currently intended for research use only. They are not for use in diagnostic procedures.